Chelsea Therapeutics, Inc. (CHTP) Announces The Expiration Of The Hart-Scott-Rodino Waiting Period In Relation To The Proposed Acquisition Of Chelsea Therapeutics By H. Lundbeck A/S (LUN.CO)
6/6/2014 9:13:46 AM
CHARLOTTE, N.C., June 6, 2014 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act") in connection with the previously announced Agreement and Plan of Merger, dated as of May 7, 2014 (the "Merger Agreement"), by and among Chelsea, H. Lundbeck A/S ("Lundbeck"), and Charlie Acquisition Corp., an indirect wholly owned subsidiary of Lundbeck ("Acquisition Sub").
Help employers find you! Check out all the jobs and post your resume.
comments powered by